Cannabis Law Report

SEPTEMBER 2, 2021

The Contract contains no minimum testing requirement; it stipulates a fixed monthly fee for sample collection site services and a separate fixed fee per individual COVID-19 test. The initial Contract term is one year and includes two one-year options for renewal exercisable at the College’s discretion.

Clinical Trials 76

Clinical Trials Research and Development Therapy Collective 76

Cannabis Law Report

JULY 21, 2021

. “The Chronic Pain & Fatigue Research Center at the University of Michigan brings incomparable experience with evaluating treatments for fibromyalgia and other chronic pain indications, and there is nothing more important to our collective team than creating therapies that will address the daily distress of these patients.”

Clinical Trials 105

Clinical Trials Chronic Pain Research and Development Treatment 105

Cannabis Law Report

SEPTEMBER 15, 2021

This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. The FDA has received adverse event reports involving delta-8 THC-containing products. brownies, gummies).

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

JULY 28, 2021

Additionally, as previously announced on January 21, 2021, Unifor and Aleafia entered into an exclusive 10-year agreement to support union members, retirees and their eligible dependents that receive medical cannabis insurance coverage clinics through Unifor’s collective bargaining agreements. The recent addition of KGK Science Inc.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

JULY 7, 2021

As a collective enterprise, Ketamine One is dedicated to helping solve the growing need for safe and accessible mental health therapy. The recent addition of KGK Science Inc. On behalf of: KETAMINE ONE. ” Adam Deffett ” Adam Deffett, Interim CEO. For further information, please contact: Nick Kuzyk, Investor Relations.

Research and Development 98

Research and Development Treatment Therapy Banking 98

Cannabis Law Report

DECEMBER 1, 2021

Join Chacruna and mental health experts and activists, Allison Feduccia, PhD, Vilmarie Fraguada Narloch, PsyD, Kylea Taylor, MS, LMFT, and Emma Knighton, MA, LMHC, to discuss topics around standards of care and accountability for practitioners in the psychedelic-therapy space, addressing issues of power, hierarchy, and abuse.

Safety 52

Safety Medicine Therapy Research and Development 52

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.” ABOUT THE NATIONAL PSYCHEDELICS ASSOCIATION.

Research and Development 52

Research and Development Therapy Clinical Trials Safety 52

Cannabis Law Report

JUNE 17, 2021

Silo Wellness is a publicly traded company on the CSE with a consumer-facing platform for the sale of functional mushroom products, psilocybin mushroom production in Jamaica, and the facilitation of psychedelic wellness retreats in both Jamaica and Oregon that incorporate a variety of psychedelic-augmented therapies. ir@silowellness.com.

Research and Development 75

Research and Development Therapy Access Media 75

The Joint Blog

AUGUST 30, 2020

Many seniors likely experimented first-hand with cannabis during their youth and are now returning to it as a potential therapy to mitigate many of the health-related symptoms that come with older age, including chronic pain. No significant associations were observed between the frequency of use and adverse events.

Marijuana 52

Marijuana Chronic Pain Events Therapy 52

Cannabis Law Report

DECEMBER 9, 2021

These describe technology and infrastructure for the collection of precise, multimodal, multivalent data that can be processed via machine learning, artificial intelligence, signal processes, and other statistical methods to yield clinically meaningful output to satisfy the requirements of the IFU. . NEW YORK , Dec. ” About MindMed.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

DECEMBER 9, 2021

Johnson recently reported his interim results at Microdose’s Psychedelic Medicine Business Event, from his current smoking cessation study, utilizing a single macro-dose of psilocybin. Mydecine has seen significant progress and data collection around other lead candidates and has filed two full patent applications in the past 60 days.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

OCTOBER 12, 2021

Mary Hartnett, Director of Medical Services at Sarah Lawrence College, stated, “safeCircle was our choice given the convenience of its on-site sample collection process, access to high-sensitivity RT-PCR-based testing with rapid turnaround times, ability to scale with our needs, and capacity to ease our administrative burdens.

Programs 40

Programs Clinical Trials Research and Development Therapy 40

Puff Puff Post

MARCH 19, 2020

The company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and 8 Fold. is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.

Business 84

Business CBD Events Retail 84

Cannabis Law Report

NOVEMBER 5, 2021

Sample collection for weekly COVID-19 pooled testing can be performed in-person (supervised) or via self-collection kits 1. 1 Availability of self-collection kits is subject to pending regulatory approval. Tests results are returned within 24 hours of sample receipt at ADCL. About Applied DNA Sciences.

Compliance 40

Compliance Compliance Research and Development Therapy 40

Cannabis Law Report

NOVEMBER 23, 2021

Hosted by the Canadian Country Music Association® (“CCMA”) in London, Ontario from November 26-29, 2021, the event will celebrate country music in Canada and will culminate with the 2021 CCMA Awards Show, which will be broadcast in a live special on November 29, 2021. cannabis beverage company Keef Brands.

Media 52

Media Events Business Therapy 52

Cannabis Law Report

DECEMBER 8, 2021

Provision should be made for the plants to be in any event not visible to anyone passing by on the public highway. conditio sine qua non in the event of possible criminal prosecution. In the event of refusal of payment or of dispute, the report is drawn up in accordance with common law. community gardens).

Recreational 52

Recreational Seed-To-Sale Consumption Events 52

Cannabis Law Report

JULY 28, 2021

Collectively the studies currently being undertaken by the Company aim to identify and provide focus to novel opportunities in oncology by revealing optimal drug combinations and situations where PD-001 can prevent, lessen, or reverse chemoresistance, and/or provide additive/synergistic benefit to existing treatments. References: Yasuda, K.,

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

The Joint Blog

JULY 29, 2021

Collective reports show that CBD oil helps in reducing the symptoms of PTSD, such as nightmares and reduplication of the distressing event. This study has been attributed to both discrete treatments for PTSD and other Cognitive Behavioral Therapy (CBT). CBD for Other Neurological Disorders.

Oil 55

Oil CBD Pharmaceutical Sleep 55

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

MMJ Recs

OCTOBER 2, 2023

ZenLeaf Collective – Los Angeles ZenLeaf Collective is a premier medical marijuana dispensary in Los Angeles, known for its exceptional customer service and top-tier cannabis products. With an emphasis on education, The Green Door offers workshops and events to empower patients with knowledge about medical cannabis.

Dispensary 52

Dispensary Patients Environment Conditions 52

Cannabis Law Report

JANUARY 28, 2022

BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with #1 U.S. Forward-Looking Disclaimer.

Extraction 52

Extraction Hash Seed-To-Sale Topical 52

Puff Puff Post

NOVEMBER 5, 2019

EB a collective name of a group of genetic disorders of connective tissues that affects individuals from birth and is characterized by fragile skin that is easily damaged, leading to extensive blistering and wounding. For more information, visit www.inmedpharma.com. About Epidermolysis Bullosa (EB). About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Puff Puff Post

NOVEMBER 5, 2019

EB a collective name of a group of genetic disorders of connective tissues that affects individuals from birth and is characterized by fragile skin that is easily damaged, leading to extensive blistering and wounding. For more information, visit www.inmedpharma.com. About Epidermolysis Bullosa (EB). About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Cannabis Law Report

JANUARY 10, 2020

The usual sequence of events is that a marijuana business receives an IRS determination that they have a deficiency attributable to income adjustments because the business is not allowed deductions under Section 280E. Assistance Collective Corp. purchase cost of inventory throughout the year + (plus). Patients Mut.

Marijuana 45

Marijuana Business Decriminalization Legislation 45

Puff Puff Post

MARCH 19, 2020

The company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and 8 Fold. is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.

Business 40

Business CBD Events Retail 40

Cannabis Law Report

MARCH 19, 2020

As indicated by FDA’s recent announcement, the collection of data about the risks and benefits of CBD remains a priority for the agency. Regulatory enforcement and litigation activity related to CBD products will continue while FDA continues its collection information. are adulterated).

CBD 45

CBD Research and Development Seed-To-Sale Data 45

Cannabis Law Report

DECEMBER 21, 2021

This service is available to businesses, K-12 schools, universities, event venues, medical offices, hospitality groups, and more to facilitate the safe return of people to in-person environments. Tests include on-site rapid antigen (results in under 20 minutes) and on-site RT-PCR sample collection (results in 24 hours).

Research and Development 40

Research and Development Supply Chain Data Business 40

Cannabis Law Report

NOVEMBER 7, 2019

His seed was planted after he observed the significant positive impact of cannabis-based therapy for PTSD sufferers caused by trauma and war experiences of military veterans and first responders. Huppert was one of the first entrepreneurs to enter the medicinal cannabis space in Australia.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

SEPTEMBER 20, 2021

BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with #1 U.S.

Hash 40

Hash Seed-To-Sale Research and Development Topical 40

Cannabis Law Report

NOVEMBER 24, 2021

Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. Data collection. 23), followed by adverse events ( n ?=?15) 15) and toxicity ( n ?=?9), 9), and drug interactions ( n ? Conclusion.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 24, 2019

Politicians are listening closely to the public discussions and consultations being raised at Cannabis educational events about how to move forward. As an overseas collectivity of France, Saint Barthélemy is subject to French law and all international conventions signed by France.[1] It has been said that consultations are the ?rst

Law 45

Law Medicine Decriminalization Oil 45

Greencamp

OCTOBER 3, 2018

People develop PTSD after experiencing a traumatic event or an event that is perceived as such. Does cannabis aid in forgetting traumatic events or just boosts dopamine, increasing the overall feelings of pleasure? Sufferers also avoid thinking or talking about the traumatic event.

Research and Development 111

Research and Development Terpenes Events Strains 111

Cannabis Law Report

FEBRUARY 14, 2022

A recent representative opinion poll of more than 1,000 Australians by Essential Research found that only a small minority was aware of the immense promise of psychedelic-assisted therapy, with just 11% of those asked aware of the medicinal properties of these substances and their potential use in controlled settings.

Medicine 52

Medicine Access Therapy Treatment 52

The Cannigma

DECEMBER 12, 2022

The results are so compelling that the FDA has categorized magic mushrooms as a “breakthrough therapy” for depression, and is committed to fast tracking its approval. History: MDMA was first synthesized in 1912, but it didn’t become popular until 1970, when therapists began to utilize it to enhance openness in therapy sessions.

History 140

History Microdosing Research and Development Clinical Trials 140

Cannabis Law Report

DECEMBER 14, 2021

During the Phase 1 trial, minimal adverse events were reported, and IGC-AD1 was tolerated with no safety concerns identified by an independent Data Safety Monitoring Board. Safety and Tolerability (S&T) was assessed by asking participants to record Adverse Events (AEs). The average age was 80.9 In addition, 66.7%

Clinical Trials 40

Clinical Trials Safety Data Patients 40

Cannabis Law Report

OCTOBER 25, 2021

The test is also intended for use with anterior nasal swab specimens that are self-collected in the presence of an HCP from individuals without symptoms or other reasons to suspect COVID-19 when tested at least weekly and with no more than 168 hours between serially collected specimens. For Applied DNA: Investor: Sanjay M.

Research and Development 40

Research and Development Therapy Collective Treatment 40